Kilitch Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE729D01010
  • NSEID: KILITCH
  • BSEID: 524500
INR
337.20
-6.05 (-1.76%)
BSENSE

Dec 05

BSE+NSE Vol: 4.1 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
16.08
16.08
15.58
15.58
15.49
15.43
Share Warrants & Outstandings
Total Reserve
185.89
159.85
130.66
120.65
111.28
101.63
Shareholder's Funds
202.33
176.29
151.60
139.09
127.13
118.25
Minority Interest
-1.87
-0.62
-1.02
1.21
2.35
2.22
Long-Term Borrowings
27.77
0.00
0.00
0.00
0.00
0.00
Secured Loans
27.77
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-2.88
-2.56
-1.98
-1.51
-1.28
-0.97
Other Long Term Liabilities
0
0
0
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.25
0.17
0.07
0.28
0.38
0.39
Total Non-Current Liabilities
25.14
-2.39
-1.91
-1.24
-0.90
-0.58
Current Liabilities
Trade Payables
54.16
25.59
40.87
42.87
53.65
7.10
Other Current Liabilities
7.01
5.59
4.29
4.97
4.03
1.38
Short Term Borrowings
21.65
31.65
22.19
20.43
14.80
12.61
Short Term Provisions
1.48
1.39
1.52
1.01
0.83
0.88
Total Current Liabilities
84.31
64.22
68.87
69.28
73.32
21.97
Total Liabilities
309.90
237.50
217.54
208.34
201.90
141.86
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
117.93
112.39
111.28
108.05
71.01
70.59
Less: Accumulated Depreciation
53.52
50.41
47.06
43.51
41.05
39.06
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
64.41
61.98
64.22
64.54
29.96
31.53
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
47.29
5.96
3.62
3.16
65.48
29.60
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
22.84
22.83
22.66
23.93
23.88
24.05
Long Term Loans & Advances
1.42
0.72
0.62
0.46
0.44
0.36
Other Non Current Assets
0.02
0.01
0.02
2.14
1.76
0.54
Total Non-Current Assets
135.99
91.51
91.14
94.23
121.53
86.08
Current Assets Loans & Advances
Current Investments
49.52
49.43
39.20
47.23
36.40
27.81
Inventories
15.31
3.99
2.04
5.00
3.59
5.56
Sundry Debtors
84.74
63.22
54.29
41.41
22.92
15.86
Cash and Bank
9.85
19.64
19.98
10.06
12.50
2.80
Other Current Assets
6.53
1.82
0.57
0.39
0.08
0.04
Short Term Loans and Advances
7.97
7.89
10.33
10.00
4.87
3.72
Total Current Assets
173.92
145.99
126.40
114.10
80.36
55.79
Net Current Assets (Including Current Investments)
89.61
81.78
57.53
44.83
7.05
33.81
Total Current Assets Excluding Current Investments
124.40
96.56
87.21
66.87
43.96
27.98
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
309.90
237.50
217.54
208.34
201.90
141.86
Contingent Liabilities
0.76
1.06
0.76
0.76
0.76
5.80
Total Debt
49.42
31.65
0.00
0.00
0.00
0.00
Book Value per share (adjusted)
123.118626817764
107.274969173859
92.0674064940403
87.35051768344
80.2947566202807
74.9809171510775
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 56.15% vs 42.63% in Mar 2024

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 64.42% vs 0.15% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 0.04% vs 0.75% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 19.13% vs 15.50% in Mar 2024

Compare Balance Sheet Results of Kilitch Drugs
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
16.08
48.29
-32.21
-66.70%
Share Warrants & Outstandings
Total Reserve
185.89
468.45
-282.56
-60.32%
Shareholder's Funds
202.33
518.35
-316.02
-60.97%
Minority Interest
-1.87
0.00
-1.87
0.00%
Long-Term Borrowings
27.77
16.48
11.29
68.51%
Secured Loans
27.77
2.04
25.73
1,261.27%
Unsecured Loans
0.00
14.45
-14.45
-100.00%
Deferred Tax Assets / Liabilities
-2.88
9.32
-12.20
-130.90%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.25
10.89
-10.64
-97.70%
Total Non-Current Liabilities
25.14
36.70
-11.56
-31.50%
Current Liabilities
Trade Payables
54.16
119.41
-65.25
-54.64%
Other Current Liabilities
7.01
36.68
-29.67
-80.89%
Short Term Borrowings
21.65
131.30
-109.65
-83.51%
Short Term Provisions
1.48
1.57
-0.09
-5.73%
Total Current Liabilities
84.31
288.97
-204.66
-70.82%
Total Liabilities
309.90
844.01
-534.11
-63.28%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
117.93
305.54
-187.61
-61.40%
Less: Accumulated Depreciation
53.52
97.13
-43.61
-44.90%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
64.41
208.41
-144.00
-69.09%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
47.29
99.38
-52.09
-52.41%
Intangible assets under development
0.00
13.81
-13.81
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
22.84
0.06
22.78
37,966.67%
Long Term Loans & Advances
1.42
11.03
-9.61
-87.13%
Other Non Current Assets
0.02
1.57
-1.55
-98.73%
Total Non-Current Assets
135.99
334.26
-198.27
-59.32%
Current Assets Loans & Advances
Current Investments
49.52
0.00
49.52
0.00%
Inventories
15.31
169.42
-154.11
-90.96%
Sundry Debtors
84.74
214.93
-130.19
-60.57%
Cash and Bank
9.85
25.86
-16.01
-61.91%
Other Current Assets
6.53
6.82
-0.29
-4.25%
Short Term Loans and Advances
7.97
92.71
-84.74
-91.40%
Total Current Assets
173.92
509.75
-335.83
-65.88%
Net Current Assets (Including Current Investments)
89.61
220.78
-131.17
-59.41%
Total Current Assets Excluding Current Investments
124.40
509.75
-385.35
-75.60%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
309.90
844.01
-534.11
-63.28%
Contingent Liabilities
0.76
17.13
-16.37
-95.56%
Total Debt
49.42
147.79
-98.37
-66.56%
Book Value per share (adjusted)
123.12
107.35
15.77
14.69%
Annual - Borrowings
Borrowings 49.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 56.15% vs 42.63% in Mar 2024

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 111.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 64.42% vs 0.15% in Mar 2024

Annual - Investments
Investments 22.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.04% vs 0.75% in Mar 2024

Annual - Current Assets
Current Assets 173.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 19.13% vs 15.50% in Mar 2024